Cancer News and Research

Latest Cancer News and Research

Ago2 protein helps generate microRNAs: CSHL researchers

MicroRNAs are small bits of RNA within cells that wield enormous power. They influence virtually every biological process by controlling the "expression" of genes. Helping them in exerting this control is a unique class of proteins called Argonautes.

29 Apr 2010

Pain Therapeutics reports net loss of $1.0 million for first-quarter 2010

Pain Therapeutics, Inc., a biopharmaceutical company, today reported first quarter 2010 financial results. Net loss for Q1 2010 was $1.0 million, or $0.02 per share, compared to a net loss of $1.8 million, or $0.04 per share, for Q1 2009.

29 Apr 2010

OSI Pharmaceuticals announces European Commission's approval of Tarceva for NSCLC

OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, received approval from the European Commission for Tarceva as a monotherapy maintenance treatment in patients with advanced non-small cell lung cancer (NSCLC) whose disease remains largely unchanged (stable disease) after platinum-based initial chemotherapy.

29 Apr 2010

Physicists and oncologists to develop novel ultra sensitive platform for early cancer detection

The SPEDOC project will create the precursor to future devices for individualized diagnosis and monitoring of cancer therapy, which will allow the illness to be treated in earlier stages and at lower doses, reducing or preventing current secondary effects.

29 Apr 2010

New report evaluating use of SBRT in lung cancer treatment released

The American Society for Radiation Oncology has released its Emerging Technology Committee's report evaluating the use of stereotactic body radiotherapy in lung cancer treatment.

29 Apr 2010

Experts discuss recent advancements in personalized medicine for treating childhood disorders

Many of the world's leading experts in pediatric pharmacogenomics and personalized medicine are gathering today at a first-of-its-kind conference in Kansas City to change the way childhood diseases and illnesses are treated.

29 Apr 2010

HHS Secretary's statement on WellPoint's announcement to end practice of rescissions

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius released the following statement today on WellPoint's announcement that it intends to end the practice of rescinding patients' coverage in advance of the Affordable Care Act's requirement that insurers stop this practice starting this fall. WellPoint's announcement comes after Secretary Sebelius sent a letter on April 22 urging the company to immediately stop the practice of rescinding coverage for patients who become ill.

29 Apr 2010

New EDUCARE project to train healthcare workers combat cancer epidemic in Africa

Roche announced today the launch of the EDUCARE project, which, in concert with IAEA, will provide support to help combat the growing cancer epidemic in sub-Saharan Africa.

29 Apr 2010

New method may aid in diagnosing lung cancer more effectively

Doctors may soon be able to diagnose lung cancer more effectively thanks to research performed at the National Institute of Standards and Technology (NIST), where scientists have found ways both to increase the accuracy of computed tomography (CT) scans and to lessen the amount of time necessary to perceive telltale changes in lung tissue.*

29 Apr 2010

WellPoint profits rise 51 percent amid scrutiny on several fronts

WellPoint, the U.S. health insurer with the biggest membership, announced Wednesday that its first-quarter earnings rose 51 percent compared to last year and were boosted by a mild flu season, The Wall Street Journal reports. Medical membership fell 2.1% to 33.8 million as of March 31 from a year earlier but rose by 165,000 during the quarter. The company trimmed its year-end medical membership projection to 33.1 million from 33.3 million."

29 Apr 2010

Geron reports net loss of $16.6M for first-quarter 2010

Geron Corporation today reported financial results for the three months ended March 31, 2010.

29 Apr 2010

$145M Federal Government effort to harness power of nanotechnology to improve cancer patients

A $145-million Federal Government effort to harness the power of nanotechnology to improve the diagnosis, treatment, and prevention of cancer is producing innovations that will radically improve care for the disease. That's the conclusion of an update on the status of the program, called the National Cancer Institute Alliance for Nanotechnology in Cancer.

29 Apr 2010

Study examines lifestyle-related causes of death in AIDS patients

The study, by researchers from the University of Bristol and a large group of international collaborators, examined data from the Antiretroviral Therapy Cohort Collaboration (ART-CC) which involved nearly 40,000 patients who started ART between 1996 and 2006 in Europe and North America.

29 Apr 2010

ECRI Institute's recommendations for controlling CT radiation dose

The benefits of computed tomography (CT) have increased greatly over the past decade. Now twice as powerful, it offers dynamic images of anatomy, including the beating heart. Future advancements promise to deliver even more clinical benefits. However, CT has always had a downside: it can deliver high radiation doses to patients, putting them at increased risk of developing cancer.

29 Apr 2010

Presence and type of cirrhosis complications are strong predictors of mortality: Study

A recent study by Danish researchers discovered patients with alcoholic cirrhosis had a high prevalence of complications at the time of the disease diagnosis.

29 Apr 2010

Nearly all U.S. states offer HPV vaccine to adolescent girls in juvenile justice facilities: Report

Nearly all U.S. states offer the human papillomavirus vaccine to adolescent girls who have been arrested or detained, according to a new report from The Miriam Hospital and Brown University. The study, published in the May issue of the Journal of Adolescent Health, offers the first nationwide review of HPV vaccination practices among juvenile justice facilities.

29 Apr 2010

LCA acknowledges on-going work by ODP on lung cancer screening research

Lung Cancer Alliance acknowledges the on-going work by the Office of Disease Prevention at the National Institutes of Health on lung cancer screening research and the need for people who may be at risk for lung cancer to be well informed.

29 Apr 2010

Fluorescent inhibitors hold promise for early-stage tumor detection

A series of novel imaging agents could light up tumors as they begin to form - before they turn deadly - and signal their transition to aggressive cancers.

29 Apr 2010

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

Kiadis Pharma today provided an update on its cell therapy product ATIR™ developed for mismatched bone marrow transplants.

29 Apr 2010

Study: Curcumin nanoparticles limit toxicity of cancer therapy

Pre-treatment with curcumin, a component of the spice turmeric, makes ovarian cancer cells more vulnerable to chemotherapy and radiotherapy. Researchers writing in BioMed Central's open access Journal of Ovarian Research found that delivering the curcumin via very small (less than 100nm) nanoparticles enhanced the sensitizing effect.

29 Apr 2010

Cancer News and Research

Latest Cancer News and Research

Ago2 protein helps generate microRNAs: CSHL researchers

Pain Therapeutics reports net loss of $1.0 million for first-quarter 2010

OSI Pharmaceuticals announces European Commission's approval of Tarceva for NSCLC

Physicists and oncologists to develop novel ultra sensitive platform for early cancer detection

New report evaluating use of SBRT in lung cancer treatment released

Experts discuss recent advancements in personalized medicine for treating childhood disorders

HHS Secretary's statement on WellPoint's announcement to end practice of rescissions

New EDUCARE project to train healthcare workers combat cancer epidemic in Africa

New method may aid in diagnosing lung cancer more effectively

WellPoint profits rise 51 percent amid scrutiny on several fronts

Geron reports net loss of $16.6M for first-quarter 2010

$145M Federal Government effort to harness power of nanotechnology to improve cancer patients

Study examines lifestyle-related causes of death in AIDS patients

ECRI Institute's recommendations for controlling CT radiation dose

Presence and type of cirrhosis complications are strong predictors of mortality: Study

Nearly all U.S. states offer HPV vaccine to adolescent girls in juvenile justice facilities: Report

LCA acknowledges on-going work by ODP on lung cancer screening research

Fluorescent inhibitors hold promise for early-stage tumor detection

ATIR shows better clinical results in patients receiving mismatched bone marrow transplantation

Study: Curcumin nanoparticles limit toxicity of cancer therapy

Industry Focus: Cell & Gene Therapy eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in